Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 8.18 | Cytotoxicity against human T98G cells expressing mutant p53 after 48 hrs by MTT assay | ChEMBL. | 22564383 |
MIC (functional) | = 6.34 uM | Antifungal activity against Candida albicans ATCC 18804 after 24 hrs | ChEMBL. | 21353348 |
MST (functional) | = 0.1 day | Antimalarial activity against Plasmodium berghei KBG 173 infected in ICR/HA Swiss mouse assessed as increase in mean survival time at 40 mg/kg, sc administered 72 hrs post infection | ChEMBL. | 376848 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 22564383 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.